Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1954 1
1955 4
1956 1
1957 2
1958 3
1959 2
1960 1
1961 3
1962 3
1963 5
1964 6
1965 8
1966 5
1967 6
1968 8
1969 12
1970 7
1971 12
1972 17
1973 23
1974 28
1975 20
1976 17
1977 19
1978 26
1979 19
1980 33
1981 23
1982 30
1983 35
1984 45
1985 56
1986 71
1987 75
1988 77
1989 105
1990 83
1991 80
1992 99
1993 67
1994 70
1995 86
1996 88
1997 115
1998 84
1999 90
2000 86
2001 104
2002 118
2003 103
2004 108
2005 124
2006 129
2007 137
2008 127
2009 147
2010 127
2011 128
2012 149
2013 132
2014 157
2015 172
2016 199
2017 253
2018 274
2019 279
2020 266
2021 301
2022 303
2023 80
Text availability
Article attribute
Article type
Publication date

Search Results

5,166 results
Results by year
Filters applied: . Clear all
Page 1
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes.
Nagasaki J, Inozume T, Sax N, Ariyasu R, Ishikawa M, Yamashita K, Kawazu M, Ueno T, Irie T, Tanji E, Morinaga T, Honobe A, Ohnuma T, Yoshino M, Iwata T, Kawase K, Sasaki K, Hanazawa T, Kochin V, Kawamura T, Matsue H, Hino M, Mano H, Suzuki Y, Nishikawa H, Togashi Y. Nagasaki J, et al. Among authors: yamashita k. Cell Rep. 2022 Feb 1;38(5):110331. doi: 10.1016/j.celrep.2022.110331. Cell Rep. 2022. PMID: 35108529 Free article.
Structural basis for channel conduction in the pump-like channelrhodopsin ChRmine.
Kishi KE, Kim YS, Fukuda M, Inoue M, Kusakizako T, Wang PY, Ramakrishnan C, Byrne EFX, Thadhani E, Paggi JM, Matsui TE, Yamashita K, Nagata T, Konno M, Quirin S, Lo M, Benster T, Uemura T, Liu K, Shibata M, Nomura N, Iwata S, Nureki O, Dror RO, Inoue K, Deisseroth K, Kato HE. Kishi KE, et al. Among authors: yamashita k. Cell. 2022 Feb 17;185(4):672-689.e23. doi: 10.1016/j.cell.2022.01.007. Epub 2022 Feb 2. Cell. 2022. PMID: 35114111 Free PMC article.
History and emerging trends in chemotherapy for gastric cancer.
Yamashita K, Hosoda K, Niihara M, Hiki N. Yamashita K, et al. Ann Gastroenterol Surg. 2021 Feb 1;5(4):446-456. doi: 10.1002/ags3.12439. eCollection 2021 Jul. Ann Gastroenterol Surg. 2021. PMID: 34337293 Free PMC article. Review.
Structure of the type V-C CRISPR-Cas effector enzyme.
Kurihara N, Nakagawa R, Hirano H, Okazaki S, Tomita A, Kobayashi K, Kusakizako T, Nishizawa T, Yamashita K, Scott DA, Nishimasu H, Nureki O. Kurihara N, et al. Among authors: yamashita k. Mol Cell. 2022 May 19;82(10):1865-1877.e4. doi: 10.1016/j.molcel.2022.03.006. Epub 2022 Apr 1. Mol Cell. 2022. PMID: 35366394 Free PMC article.
Manifestation purpurique d’un myxome auriculaire infecté.
Yamamoto T, Yamashita K, Hagiwara H. Yamamoto T, et al. Among authors: yamashita k. CMAJ. 2021 May 25;193(21):E788-E789. doi: 10.1503/cmaj.201351-f. CMAJ. 2021. PMID: 34035064 Free PMC article. French. No abstract available.
Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors.
Akiyama T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, Tan BJY, Yonemura A, Semba T, Yamasaki J, Komohara Y, Ohnishi K, Wei F, Fu L, Zhang J, Kitamura F, Yamashita K, Eto K, Iwagami S, Tsukamoto H, Umemoto T, Masuda M, Nagano O, Satou Y, Saya H, Tan P, Baba H, Ishimoto T. Akiyama T, et al. Among authors: yamashita k. Cancer Res. 2023 Mar 2;83(5):753-770. doi: 10.1158/0008-5472.CAN-22-1890. Cancer Res. 2023. PMID: 36543251
Anti-AQP4 autoantibodies promote ATP release from astrocytes and induce mechanical pain in rats.
Ishikura T, Kinoshita M, Shimizu M, Yasumizu Y, Motooka D, Okuzaki D, Yamashita K, Murata H, Beppu S, Koda T, Tada S, Shiraishi N, Sugiyama Y, Miyamoto K, Kusunoki S, Sugimoto T, Kumanogoh A, Okuno T, Mochizuki H. Ishikura T, et al. Among authors: yamashita k. J Neuroinflammation. 2021 Aug 21;18(1):181. doi: 10.1186/s12974-021-02232-w. J Neuroinflammation. 2021. PMID: 34419102 Free PMC article.
Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer.
Fu L, Yonemura A, Yasuda-Yoshihara N, Umemoto T, Zhang J, Yasuda T, Uchihara T, Akiyama T, Kitamura F, Yamashita K, Okamoto Y, Bu L, Wei F, Hu X, Liu Y, Ajani JA, Tan P, Baba H, Ishimoto T. Fu L, et al. Among authors: yamashita k. Gastric Cancer. 2022 May;25(3):542-557. doi: 10.1007/s10120-022-01283-z. Epub 2022 Feb 15. Gastric Cancer. 2022. PMID: 35166958
Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial.
Muranushi H, Kanda J, Kobayashi M, Maeda T, Kitano T, Tsuji M, Ueda Y, Ishikawa T, Nohgawa M, Watanabe M, Imada K, Moriguchi T, Itoh M, Ohno H, Yonezawa A, Hirata H, Arima N, Asagoe K, Anzai N, Nagata K, Yasuno S, Kuwabara Y, Kitao H, Kim I, Kawagishi K, Ueshima K, Tominari S, Nakayama T, Yamashita K, Takaori-Kondo A. Muranushi H, et al. Among authors: yamashita k. Hematology. 2022 Dec;27(1):239-248. doi: 10.1080/16078454.2022.2032915. Hematology. 2022. PMID: 35152852 Clinical Trial.
5,166 results